Aaron Patrick, Ph.D.

Affiliations: 
2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology
Google:
"Aaron Patrick"

Parents

Sign in to add mentor
Heide L. Ford grad student 2009 University of Colorado, Denver
 (Structure-function analysis of the Six1/Eya transcriptional complex.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blevins MA, Towers CG, Patrick AN, et al. (2015) The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opinion On Therapeutic Targets. 19: 213-25
Krueger AB, Drasin DJ, Lea WA, et al. (2014) Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration. The Journal of Biological Chemistry. 289: 16349-61
Kohrt D, Crary J, Zimmer M, et al. (2014) CDK6 binds and promotes the degradation of the EYA2 protein. Cell Cycle (Georgetown, Tex.). 13: 62-71
Patrick AN, Cabrera JH, Smith AL, et al. (2013) Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nature Structural & Molecular Biology. 20: 447-53
Patrick A, Blevins M, Krueger A, et al. (2013) Abstract B102: Targeting the SIX1/EYA transcriptional complex as a potential anti-cancer therapy. Molecular Cancer Therapeutics. 12
Wang CA, Jedlicka P, Patrick AN, et al. (2012) SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. The Journal of Clinical Investigation. 122: 1895-906
Qamar L, Deitsch E, Patrick AN, et al. (2012) Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer. Gynecologic Oncology. 125: 451-7
Ford H, Patrick A, Varella-Garcia M. (2011) SIX1 (sine oculis homeobox homolog 1) (mammalian) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Patrick A, Cabrera J, Zhao R, et al. (2011) Abstract C127: Crystal structure of the SIX1/EYA transcriptional complex reveals ways to inhibit SIX1-mediated breast tumorigenesis/metastasis. Molecular Cancer Therapeutics. 10
Patrick AN, Schiemann BJ, Yang K, et al. (2009) Biochemical and functional characterization of six SIX1 Branchio-oto-renal syndrome mutations. The Journal of Biological Chemistry. 284: 20781-90
See more...